Cargando…
Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction
This study tested whether human umbilical cord–derived mesenchymal stem cells (HUCDMSCs) treatment effectively protected the rat lung against acute respiratory distress syndrome (ARDS) injury, and benefits of early and dose-dependent treatment. Rat pulmonary epithelial cell line L2 (PECL2) were cate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469224/ https://www.ncbi.nlm.nih.gov/pubmed/37592717 http://dx.doi.org/10.1177/09636897231190178 |
_version_ | 1785099395695378432 |
---|---|
author | Lin, Kun-Chen Fang, Wen-Feng Sung, Pei-Hsun Huang, Kuo-Tung Chiang, John Y. Chen, Yi-Ling Huang, Chi-Ruei Li, Yi-Chen Lee, Mel S. Yip, Hon-Kan |
author_facet | Lin, Kun-Chen Fang, Wen-Feng Sung, Pei-Hsun Huang, Kuo-Tung Chiang, John Y. Chen, Yi-Ling Huang, Chi-Ruei Li, Yi-Chen Lee, Mel S. Yip, Hon-Kan |
author_sort | Lin, Kun-Chen |
collection | PubMed |
description | This study tested whether human umbilical cord–derived mesenchymal stem cells (HUCDMSCs) treatment effectively protected the rat lung against acute respiratory distress syndrome (ARDS) injury, and benefits of early and dose-dependent treatment. Rat pulmonary epithelial cell line L2 (PECL2) were categorized into G1 (PECL2), G2 (PECL2 + healthy rat lung-derived extraction/50 mg/ml co-cultured for 24 h), G3 (PECL2 + ARDS rat lung-derived extraction/50 mg/ml co-cultured for 24 h), and G4 (condition as G3 + HUCDMSCs/1 × 10(5)/co-cultured for 24 h). The result showed that the protein expressions of inflammatory (HMGB-1/TLR-2/TLR-4/MAL/TRAM/MyD88/TRIF/TRAF6/IkB/NF-κB/IL-1β/TNF-α), oxidative-stress/mitochondrial-damaged (NOX-1/NOX-2/ASK1/p-MKK4/p-MKK7/JNKs/JUN/cytosolic-cytochrome-C/cyclophilin-D/DRP1), and cell-apoptotic/fibrotic (cleaved-caspase 3/cleaved-PARP/TGF-β/p-Smad3) biomarkers were significantly increased in G3 than in G1/G2 and were significantly reversed in G4 (all P < 0.001), but they were similar between G1/G2. Adult male rats (n = 42) were equally categorized into group 1 (normal control), group 2 (ARDS only), group 3 [ARDS + HUCDMSCs/1.2 × 10(6) cells intravenous administration at 3 h after 48 h ARDS induction (i.e., early treatment)], group 4 [ARDS + HUCDMSCs/1.2 × 10(6) cells intravenous administration at 24 h after 48 h ARDS induction (late treatment)], and group 5 [ARDS + HUCDMSCs/1.2 × 10(6) cells intravenous administration at 3 h/24 h after-48 h ARDS induction (dose-dependent treatment)]. By day 5 after ARDS induction, the SaO(2)%/immune regulatory T cells were highest in group 1, lowest in group 2, significantly lower in group 4 than in groups 3/5, and significantly lower in group 3 than in group 5, whereas the circulatory/bronchioalveolar lavage fluid inflammatory cells (CD11b-c+/LyG6+/MPO+)/circulatory immune cells (CD3-C4+/CD3-CD8+)/lung-leakage-albumin level/lung injury score/lung protein expressions of inflammatory (HMGB-1/TLR-2/TLR-4/MAL/TRAM/MyD88/TRIF/TRAF6/IκB-β/p-NF-κB/IL-1β/TNF-α)/fibrotic (p-SMad3/TGF-β), apoptosis (mitochondrial-Bax/cleaved-caspase-3)/oxidative-cell-stress (NOX-1/NOX-2/ASK1/p-MKK4/p-MKK7/p-JNKs/p-cJUN)/mitochondrial damaged (cyclophilin-D/DRP1/cytosolic-cytochrome-C) biomarkers displayed an opposite pattern of SaO(2)% among the groups (all P < 0.0001). Early administration was superior to and two-dose counterpart was even more superior to late HUCDMSCs treatment for protecting the lung against ARDS injury. |
format | Online Article Text |
id | pubmed-10469224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-104692242023-09-01 Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction Lin, Kun-Chen Fang, Wen-Feng Sung, Pei-Hsun Huang, Kuo-Tung Chiang, John Y. Chen, Yi-Ling Huang, Chi-Ruei Li, Yi-Chen Lee, Mel S. Yip, Hon-Kan Cell Transplant Original Article This study tested whether human umbilical cord–derived mesenchymal stem cells (HUCDMSCs) treatment effectively protected the rat lung against acute respiratory distress syndrome (ARDS) injury, and benefits of early and dose-dependent treatment. Rat pulmonary epithelial cell line L2 (PECL2) were categorized into G1 (PECL2), G2 (PECL2 + healthy rat lung-derived extraction/50 mg/ml co-cultured for 24 h), G3 (PECL2 + ARDS rat lung-derived extraction/50 mg/ml co-cultured for 24 h), and G4 (condition as G3 + HUCDMSCs/1 × 10(5)/co-cultured for 24 h). The result showed that the protein expressions of inflammatory (HMGB-1/TLR-2/TLR-4/MAL/TRAM/MyD88/TRIF/TRAF6/IkB/NF-κB/IL-1β/TNF-α), oxidative-stress/mitochondrial-damaged (NOX-1/NOX-2/ASK1/p-MKK4/p-MKK7/JNKs/JUN/cytosolic-cytochrome-C/cyclophilin-D/DRP1), and cell-apoptotic/fibrotic (cleaved-caspase 3/cleaved-PARP/TGF-β/p-Smad3) biomarkers were significantly increased in G3 than in G1/G2 and were significantly reversed in G4 (all P < 0.001), but they were similar between G1/G2. Adult male rats (n = 42) were equally categorized into group 1 (normal control), group 2 (ARDS only), group 3 [ARDS + HUCDMSCs/1.2 × 10(6) cells intravenous administration at 3 h after 48 h ARDS induction (i.e., early treatment)], group 4 [ARDS + HUCDMSCs/1.2 × 10(6) cells intravenous administration at 24 h after 48 h ARDS induction (late treatment)], and group 5 [ARDS + HUCDMSCs/1.2 × 10(6) cells intravenous administration at 3 h/24 h after-48 h ARDS induction (dose-dependent treatment)]. By day 5 after ARDS induction, the SaO(2)%/immune regulatory T cells were highest in group 1, lowest in group 2, significantly lower in group 4 than in groups 3/5, and significantly lower in group 3 than in group 5, whereas the circulatory/bronchioalveolar lavage fluid inflammatory cells (CD11b-c+/LyG6+/MPO+)/circulatory immune cells (CD3-C4+/CD3-CD8+)/lung-leakage-albumin level/lung injury score/lung protein expressions of inflammatory (HMGB-1/TLR-2/TLR-4/MAL/TRAM/MyD88/TRIF/TRAF6/IκB-β/p-NF-κB/IL-1β/TNF-α)/fibrotic (p-SMad3/TGF-β), apoptosis (mitochondrial-Bax/cleaved-caspase-3)/oxidative-cell-stress (NOX-1/NOX-2/ASK1/p-MKK4/p-MKK7/p-JNKs/p-cJUN)/mitochondrial damaged (cyclophilin-D/DRP1/cytosolic-cytochrome-C) biomarkers displayed an opposite pattern of SaO(2)% among the groups (all P < 0.0001). Early administration was superior to and two-dose counterpart was even more superior to late HUCDMSCs treatment for protecting the lung against ARDS injury. SAGE Publications 2023-08-17 /pmc/articles/PMC10469224/ /pubmed/37592717 http://dx.doi.org/10.1177/09636897231190178 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Lin, Kun-Chen Fang, Wen-Feng Sung, Pei-Hsun Huang, Kuo-Tung Chiang, John Y. Chen, Yi-Ling Huang, Chi-Ruei Li, Yi-Chen Lee, Mel S. Yip, Hon-Kan Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction |
title | Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction |
title_full | Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction |
title_fullStr | Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction |
title_full_unstemmed | Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction |
title_short | Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction |
title_sort | early and dose-dependent xenogeneic mesenchymal stem cell therapy improved outcomes in acute respiratory distress syndrome rodent through ameliorating inflammation, oxidative stress, and immune reaction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469224/ https://www.ncbi.nlm.nih.gov/pubmed/37592717 http://dx.doi.org/10.1177/09636897231190178 |
work_keys_str_mv | AT linkunchen earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT fangwenfeng earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT sungpeihsun earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT huangkuotung earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT chiangjohny earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT chenyiling earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT huangchiruei earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT liyichen earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT leemels earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction AT yiphonkan earlyanddosedependentxenogeneicmesenchymalstemcelltherapyimprovedoutcomesinacuterespiratorydistresssyndromerodentthroughamelioratinginflammationoxidativestressandimmunereaction |